Argus Research Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $162
Cardinal Health Is Maintained at Overweight by Morgan Stanley
Argus Adjusts Price Target on Cardinal Health to $162 From $148
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $166
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Organon (OGN) and Cardinal Health (CAH)
Cardinal Health's Promising Growth Under New Leadership Justifies Buy Rating
Evercore ISI Sticks to Its Buy Rating for Cardinal Health (CAH)
Cardinal Health Is Maintained at Buy by UBS
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $170
Jefferies Lifts Price Target on Cardinal Health to $170 From $150
Cardinal Health Is Maintained at Outperform by Baird
Cardinal Health Analyst Ratings
Baird Adjusts Price Target on Cardinal Health to $170 From $156
Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $157
TD Cowen Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $162
Research Alert: Cah: Business-wide Margin Expansion Leads To Earnings Beat, Guidance Raise
UBS Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $160
Cardinal Health Analyst Ratings
UBS Maintains Buy on Cardinal Health, Raises Price Target to $160
Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $140